{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:29:41Z","timestamp":1793410181809,"version":"4.5.0"},"reference-count":22,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Two distinct acute respiratory distress syndrome (ARDS) subphenotypes have been identified using data obtained at time of enrolment in clinical trials; it remains unknown if these subphenotypes are durable over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the stability of ARDS subphenotypes over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Secondary analysis of data from two randomised controlled trials in ARDS, the ARMA trial of lung protective ventilation (n=473; patients randomised to low tidal volumes only) and the ALVEOLI trial of low versus high positive end-expiratory pressure (n=549). Latent class analysis (LCA) and latent transition analysis (LTA) were applied to data from day 0 and day 3, independent of clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and main results<\/jats:title>\n                    <jats:p>In ALVEOLI, LCA indicated strong evidence of two ARDS latent classes at days 0 and 3; in ARMA, evidence of two classes was stronger at day 0 than at day 3. The clinical and biological features of these two classes were similar to those in our prior work and were largely stable over time, though class 2 demonstrated evidence of progressive organ failures by day 3, compared with class 1. In both LCA and LTA models, the majority of patients (&gt;94%) stayed in the same class from day 0 to day 3. Clinical outcomes were statistically significantly worse in class 2 than class 1 and were more strongly associated with day 3 class assignment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ARDS subphenotypes are largely stable over the first 3 days of enrolment in two ARDS Network trials, suggesting that subphenotype identification may be feasible in the context of clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thoraxjnl-2017-211090","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T12:20:25Z","timestamp":1519474825000},"page":"439-445","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":158,"title":["Stability of ARDS subphenotypes over time in two randomised controlled trials"],"prefix":"10.1136","volume":"73","author":[{"given":"Kevin","family":"Delucchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie R","family":"Famous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine B","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly E","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B Taylor","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S","family":"Calfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,24]]},"reference":[{"key":"2020050723432674000_73.5.439.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201512-2544CP"},{"key":"2020050723432674000_73.5.439.2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70097-9"},{"key":"2020050723432674000_73.5.439.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201603-0645OC"},{"key":"2020050723432674000_73.5.439.4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N Engl J Med"},{"key":"2020050723432674000_73.5.439.5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(17)30188-1","article-title":"Clinical trials in acute respiratory distress syndrome: challenges and opportunities","volume":"5","author":"Matthay","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2020050723432674000_73.5.439.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421801"},{"key":"2020050723432674000_73.5.439.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032193"},{"key":"2020050723432674000_73.5.439.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.1995"},{"key":"2020050723432674000_73.5.439.9","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200201000-00001"},{"key":"2020050723432674000_73.5.439.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000149854.61192.DC"},{"key":"2020050723432674000_73.5.439.11","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000221922.08878.49"},{"key":"2020050723432674000_73.5.439.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-008-1235-0"},{"key":"2020050723432674000_73.5.439.13","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.11.983"},{"key":"2020050723432674000_73.5.439.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200310-1434OC"},{"key":"2020050723432674000_73.5.439.15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1484"},{"key":"2020050723432674000_73.5.439.16","doi-asserted-by":"publisher","DOI":"10.2307\/1912557"},{"key":"2020050723432674000_73.5.439.17","doi-asserted-by":"publisher","DOI":"10.1007\/BF01246098"},{"key":"2020050723432674000_73.5.439.18","unstructured":"Collins LM , Flaherty BP . Latent class models for longitudinal data. In: Hagennars JA , McCutcheon AL , eds. Applied latent class analysis. New York: Cambridge University Press, 2002:287\u2013305."},{"key":"2020050723432674000_73.5.439.19","first-page":"A7791","article-title":"Latent class analysis demonstrates the stability of ARDS endotypes over time","volume":"193","author":"Famous","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2020050723432674000_73.5.439.20","doi-asserted-by":"publisher","DOI":"10.1080\/10705510701575396"},{"key":"2020050723432674000_73.5.439.21","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176344136"},{"key":"2020050723432674000_73.5.439.22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1164\/rccm.201608-1729ED","article-title":"Acute respiratory distress syndrome phenotypes and identifying treatable traits. The dawn of personalized medicine for ARDS","volume":"195","author":"Shankar-Hari","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2017-211090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:27:47Z","timestamp":1660498067000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2017-211090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,24]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,16]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/thoraxjnl-2017-211090"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211090","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732757246.793549470","asserted-by":"object"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,24]]}}}